The Pharmacist’s Role in Managing High-Risk MS Patients

In an interview with Pharmacy Times at the Consortium of Multiple Sclerosis Centers 2026, Stephanie Iyer, PhD, CPP, BCACP, a clinical pharmacist at University of North Carolina neurology clinic, presenting on management of High-risk multiple sclerosis patients, discussed what the pharmacist's role is in managing high-risk MS patients.

Iyer discussed the importance of multidisciplinary collaboration in the management of complex and high-risk MS cases, with particular emphasis on the evolving role of pharmacists within the care team.

During the discussion, Iyer highlighted how coordinated collaboration among neurologists, pharmacists, nurses, and other health care professionals has become increasingly important as MS treatment strategies grow more complex. With expanding therapeutic options, individualized treatment considerations, and ongoing safety monitoring needs, comprehensive care often requires input from multiple disciplines to help optimize patient outcomes.

The conversation also explored the unique contributions pharmacists can make throughout the treatment process for patients with MS. Iyer addressed opportunities for pharmacists to support therapy management, improve medication adherence, and assist with monitoring for adverse effects, particularly in high-risk patient populations. As disease-modifying therapies continue to evolve, pharmacists are playing a growing role in helping patients navigate treatment regimens, understand safety considerations, and manage long-term therapy expectations.

In addition, the interview underscored the importance of communication between care team members when managing patients with complex clinical needs. Collaboration may be especially valuable in patients requiring close monitoring, individualized therapy adjustments, or ongoing assessment of treatment tolerability and risk factors.

Iyer also emphasized the broader shift toward team-based MS care, reflecting the increasingly personalized nature of treatment decision-making in modern neurology practice. Pharmacists, in particular, remain highly accessible health care professionals who can provide education, reinforce adherence strategies, and support continuity of care between clinic visits.

Overall, the discussion reinforced the critical role of multidisciplinary collaboration in improving outcomes for patients with MS and highlighted the growing impact pharmacists can have in supporting safe, effective, and patient-centered disease management.